Chronic Multifocal Inflammatory Myeloneuropathy: A Novel Immunoresponsive Clinical Entity (P3.142)

Conclusions: We bring to your attention a novel case series of chronic, inflammatory immunoresponsive myeloneuropathy with very unique clinical syndrome.Disclosure: Dr. Mitrabhakdi has nothing to disclose. Dr. Goodman has nothing to disclose. Dr. Laothamatas has nothing to disclose. Dr. Lewis has received personal compensation for activities with CSL Behring, Pharnext, Novartis, and Axelacare.

Source: Neurology - April 3, 2016 Category: Neurology Authors: Mitrabhakdi, E., Goodman, B., Laothamatas, J., Lewis, R. Tags: Acquired Peripheral Neuropathies: Clinical and Pathological Aspects Source Type: research